Radiolabelling and bioequivalence of modified Tamoxifen solid lipid nanoparticles as a targeted chemotherapeutic drug
Sign Up to like & getrecommendations! Published in 2025 at "Drug Delivery and Translational Research"
DOI: 10.1007/s13346-025-01865-1
Abstract: There are several types of breast cancer where the breast's cells proliferate uncontrollably. A selective oestrogen receptor modulator called Tamoxifen citrate (TAM) is used to treat and prevent breast cancer in both men and women.… read more here.
Keywords: bioequivalence modified; radiolabelling bioequivalence; tam; drug ... See more keywords